Bioassay to present full analytical portfolio at Nordic Life Science Days Copenhagen

Heidelberg, Germany: – Specialist bioanalytical contract research organisation (CRO) Bioassay GmbH will return to the Nordic Life Science Days partnering conference, being held for the first time in Copenhagen.

Bioassay has been a prominent presence at Nordic Life Science meetings during the event’s ten-year history.

Enhanced capabilities

Once again, it will use the conference and its networking platforms to promote its impressive array of assay capabilities in the areas of Potency, Efficacy & Safety, and its physico-chemical analytical HPLC Services. Bioassay will also highlight the support it can offer to GxP development and manufacturing.

This is Bioassay’s first appearance at the Nordic conference since it became part of the US-based Reaction Biology family, further enhancing its reach and capabilities.

Assay portfolio

Bioassay’s presence at the Tenth Anniversary conference in Copenhagen will be led by its Director Business Development, Dr. Luisa Duque, who is now taking requests for meetings, either face to face or using the event’s BIO One-on-One online networking platform.

Luisa Duque commented: “It is a great pleasure to be returning to this valuable conference that is so important to the Scandinavian life sciences sector. We can show that we have a great deal to offer Nordic drug development companies in terms of our very extensive portfolio of highly targeted assay services.”

About Bioassay GmbH

Bioassay GmbH is a bioanalytical contract laboratory (CRO) specializing in the development, validation and routine performance of bioanalytical assays in the areas of Pharmacology and Toxicology.

Bioassay serves clients in the biotechnology, chemistry and cosmetics sectors and is particularly expert in carrying out potency assays under GMP for biopharmaceuticals, including therapeutic antibodies, hormones and cytokines. It offers a range of services based on in-vivo and in-vitro systems including potency assays (GMP) and toxicity Studies (GLP).

The Bioassay services portfolio focuses on the critical investigation areas of potency, efficacy, and safety, with panels that incorporate a wide range of specialized models and techniques.

Bioassay GmbH was privately founded in 2002 and since 2022 has formed part of the Reaction Biology Corporation. The company is located at Heidelberg’s Technology Park as part of a cluster of innovative biotech companies and institutions with links to Heidelberg University.

Learn more at: bioassay-online.com

About Nordic Life Science Days 2023

Nordic Life Science Days (NLSDays) is Scandinavia’s largest partnering conference for the global Life Science industries.

The event is aimed at leading decision makers from the whole Life Sciences sector, including not only biotech, pharma and Medtech but also finances, research, policy and regulatory authorities. The event has grown steadily over the past three years, from 650 participants in 2013 to some 1,500 at last year’s conference.

The Tenth Anniversary 2023 NLSDays meeting is a two-day event opening November 29 at the Bella Center in Copenhagen, the series’ first visit to Denmark.

Along with networking sessions powered by the BIO One-On-One Partnering™ system, the conference will also feature fireside chats, super sessions focusing on success stories from the Nordic life science sector, company presentations forum, an Innovative Posters competition, and the Nordic Stars pitch competition for up-and-coming innovators, competing for attractive prize packages.

The event is organized by Sweden Bio and BioNordic, with more information at: www.nlsdays.com.

Resources

Click on  bioassay-online.com for further information.